Rapidly progressive ulcerative neutrophilic dermatosis often misdiagnosed as infection.
Rapidly progressive ulcerative neutrophilic dermatosis often misdiagnosed as infection.
Common signs and symptoms can vary by wound type and severity.
A clinician evaluates the wound together with the factors that may delay healing.
Any rapidly enlarging ulcer with a violaceous border, especially after minor trauma or surgery, should be evaluated promptly. Misdiagnosis as infection and aggressive surgical debridement can dramatically worsen the disease.
Healix360 supports access to advanced mobile wound care services for patients throughout our coverage area. Services are delivered by licensed physicians and nurse practitioners experienced in the evaluation and management of chronic and complex wounds, including suspected pyoderma gangrenosum. Care is coordinated and provided directly to patients in private residences, assisted living communities, and skilled nursing facilities.
Our clinicians focus on minimizing trauma to the wound bed, applying non-adherent moisture-balanced dressings, and managing pain. Because aggressive sharp debridement can trigger pathergy and rapid extension, we coordinate closely with dermatology and rheumatology for systemic immunosuppressive therapy (corticosteroids, cyclosporine, or biologics) and reserve mechanical intervention for clearly devitalized tissue.
With appropriate systemic immunosuppression and gentle, non-traumatic local care, the majority of pyoderma gangrenosum ulcers heal within months. Recurrence is common and requires long-term coordination with the patient's specialist.
No. Despite the name, it is a non-infectious neutrophilic inflammatory disorder. Treating it as a bacterial infection with debridement and antibiotics alone often makes it worse.
Pyoderma gangrenosum demonstrates pathergy, meaning trauma triggers new or expanding lesions. Aggressive sharp debridement frequently causes rapid wound enlargement and is generally avoided.
Systemic immunosuppression with corticosteroids, cyclosporine, or biologic agents (such as infliximab) is the foundation of disease control. We coordinate local wound care with the prescribing dermatologist or rheumatologist.
Pyoderma gangrenosum is a diagnosis of exclusion based on clinical appearance, rapid course, and ruling out infection, vasculitis, and malignancy. Biopsy is sometimes used cautiously, since the biopsy itself can trigger pathergy.
Yes, medically necessary mobile wound care visits for pyoderma gangrenosum are typically covered under Medicare Part B.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.